Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Neuro-Oncology

• Publication date

  2022-06-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/neuonc/noac131PMID 35674736PMCID PMC9629449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imaging of the glioma microenvironment by TSPO PET

  2021cited by this paper
• Glioma stem cells and their roles within the hypoxic tumor microenvironment

  2021cited by this paper
• Visualizing T-Cell Responses: The T-Cell PET Imaging Toolbox

  2021cited by this paper
• 18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study

  2021cited by this paper
• Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer

  2021cited by this paper
• PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in 11C-Methionine PET and Survival

  2021cited by this paper
• Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy

  2021cited by this paper
• Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, 18F-FMISO PET, and 18F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma

  2021cited by this paper
• Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET

  2021cited by this paper
• Imaging of T-cell Responses in the Context of Cancer Immunotherapy

  2021cited by this paper
• Uncovering an Optic Nerve Sheath Meningioma Using 68Ga-DOTATATE PET/CT.

  2021cited by this paper
• PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.

  2021cited by this paper
• PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging

  2021cited by this paper
• Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.

  2021cited by this paper
• CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather

  2021cited by this paper
• PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin αvβ3 Receptors

  2021cited by this paper
• Multimodal therapy of cavernous sinus meningioma: Impact of surgery and 68Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome

  2021cited by this paper
• First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma

  2020cited by this paper
• Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells

  2020cited by this paper
• Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617

  2020cited by this paper
• In vivo imaging of cell proliferation in meningioma using 3′-deoxy-3′-[18F]fluorothymidine PET/MRI

  2020cited by this paper
• TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma.

  2020cited by this paper
• CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma

  2020cited by this paper
• High uptake of 68Ga-PSMA and 18F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes

  2020cited by this paper
• Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences

  2020cited by this paper
• A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancer

  2020cited by this paper
• PET imaging of meningioma with 18F-FLT: a predictor of tumour progression.

  2020cited by this paper
• 177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme: Proof of Concept.

  2020cited by this paper
• Simpson Grade Revisited - Intraoperative Estimation of the Extent of Resection in Meningiomas Versus Postoperative Somatostatin Receptor Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.

  2020cited by this paper
• Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

  2020cited by this paper
• Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI

  2020cited by this paper
• The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

  2020cited by this paper
• Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology

  2019cited by this paper
• PET imaging in patients with brain metastasis-report of the RANO/PET group.

  2019cited by this paper
• 18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma.

  2019cited by this paper
• Current status of PET imaging in neuro-oncology

  2019cited by this paper
• Direct comparison of [11C] choline and [18F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients

  2019cited by this paper
• The Roles of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment

  2019cited by this paper
• 18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas

  2019cited by this paper
• 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

  2019cited by this paper
• Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review

  2019cited by this paper
• 18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis

  2019cited by this paper
• Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses

  2019cited by this paper
• Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).

  2019cited by this paper
• TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis and a growth-promoting metabolic shift towards glycolysis in glioblastoma.

  2019cited by this paper
• First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting

  2019cited by this paper
• Noninvasive PET Imaging of T cells.

  2018cited by this paper
• In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine.

  2018cited by this paper
• Investigational PET tracers for high-grade gliomas.

  2018cited by this paper
• Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival

  2018cited by this paper
• Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

  2018cited by this paper
• Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy

  2018cited by this paper
• Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study

  2018cited by this paper
• Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study

  2018cited by this paper
• Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

  2018cited by this paper
• A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management

  2018cited by this paper
• Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy

  2018cited by this paper
• Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

  2018cited by this paper
• 18F-fluorothymidine PET imaging in gliomas: an update

  2017cited by this paper
• Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with 18F-fluciclovine: A Comparative Study with L-methyl-11C-methionine PET Imaging

  2017cited by this paper
• Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial

  2017cited by this paper
• Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma

  2017cited by this paper
• PET imaging in patients with meningioma—report of the RANO/PET Group

  2017cited by this paper
• Detection of immune responses after immunotherapy in glioblastoma using PET and MRI

  2017cited by this paper
• The endothelial prostate-specific membrane antigen is highly expressed in gliosarcoma and visualized by [68Ga]-PSMA-11 PET: a theranostic outlook for brain tumor patients?

  2017cited by this paper
• Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma

  2017cited by this paper
• [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

  2017cited by this paper
• Advances in neuro-oncology imaging

  2017cited by this paper
• TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

  2017cited by this paper
• First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

  2016cited by this paper
• Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy

  2016cited by this paper
• Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F]FLT-PET Imaging

  2016cited by this paper
• Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

  2016cited by this paper
• Molecular imaging of brain tumors with radiolabeled choline PET

  2016cited by this paper
• Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.

  2016cited by this paper
• 90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

  2015cited by this paper
• Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

  2015cited by this paper
• Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases

  2015cited by this paper
• Increased 68Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue

  2015cited by this paper
• Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

  2015cited by this paper
• Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.

  2015cited by this paper
• An Intra-Individual Comparison of MRI, [18F]-FET and [18F]-FLT PET in Patients with High-Grade Gliomas

  2014cited by this paper
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

  2014cited by this paper
• Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma.

  2014cited by this paper
• Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells

  2014cited by this paper
• Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases

  2014cited by this paper
• Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.

  2014cited by this paper
• A Pilot Study on EGFR-Targeted Molecular Imaging of PET/CT With 11C-PD153035 in Human Gliomas

  2014cited by this paper
• Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.

  2013cited by this paper
• Radiolabeled Amino Acids for Oncologic Imaging

  2013cited by this paper
• The role of the CXCR4 cell surface chemokine receptor in glioma biology

  2013cited by this paper
• Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates

  2013cited by this paper
• Differentiation of Glioblastomas from Metastatic Brain Tumors by Tryptophan Uptake and Kinetic Analysis: A Positron Emission Tomographic Study with Magnetic Resonance Imaging Comparison

  2013cited by this paper
• Correlation of 18F-FLT Uptake with Tumor Grade and Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas

  2012cited by this paper
• 3′-Deoxy-3′-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab

  2012cited by this paper
• The translocator protein ligand [18F]DPA-714 images glioma and activated microglia in vivo

  2012cited by this paper
• Accurate Differentiation of Recurrent Gliomas from Radiation Injury by Kinetic Analysis of α-11C-Methyl-l-Tryptophan PET

  2012cited by this paper
• 3′-Deoxy-3′-18F-Fluorothymidine PET–Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients

  2012cited by this paper
• Evaluation of 3′-deoxy-3′-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas

  2012cited by this paper
• PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer

  2011cited by this paper

• Dose optimization of stereotactic radiosurgery by 18F-FHBG PET/CT tracking of HSV-TK gene vectors in recurrent glioblastoma: A prospective controlled study

  2026cites this paper
• Imaging in Neuro-oncology

  2025cites this paper
• Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.

  2025cites this paper
• Mitochondrial Microenvironment-Activated Dual-Function Probe Enables Histological Differentiation of Malignant Glioma

  2025cites this paper
• Multiomic profiling of glioblastoma metabolic lesions reveals complex intratumoral genomic evolution and dipeptidase-1-driven vascular proliferation

  2025cites this paper
• PSMA-targeted PET imaging for brain metastases from non-prostatic solid tumors: a systematic review

  2025cites this paper
• The Role of PET/CT in Radiation Oncology for Central Nervous System Tumors.

  2025cites this paper
• Tryptophan Kynurenine Pathway-Based Imaging Agents for Brain Disorders and Oncology—From Bench to Bedside

  2025cites this paper
• Future Directions in the Treatment of Low-Grade Gliomas

  2025cites this paper
• Advanced Imaging in the Diagnosis and Response Assessment of High-Grade Glioma: AJR Expert Panel Narrative Review.

  2024cites this paper
• The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma

  2024cites this paper
• Introduction to the Special Issue on “Role of Novel Imaging Technique in Brain Tumors”

  2024cites this paper
• Challenges, Limitations and Pitfalls of PET and Advanced MRI in Patients with Brain Tumors - A Report of the PET/RANO Group.

  2024cites this paper
• Introducing the American Society of Neuroradiology PET-Guided Diagnosis and Management in Neuro-Oncology Study Group

  2024cites this paper
• Glioma

  2024cites this paper
• PET imaging of gliomas: Status quo and quo vadis?

  2024cites this paper
• [68Ga]Ga-FAPI PET/CT in brain tumors: comparison with [18F]F-FDG PET/CT

  2024cites this paper
• Theranostics and molecular imaging in Neuro-Oncology: the beginning of a new era.

  2024cites this paper
• Amino Acid PET in Neurooncology

  2023cites this paper
• Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model

  2023cites this paper
• Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas.

  2023cites this paper
• Neuro-Oncology and Positron Emission Tomography: “Just Can’t Get Enough”

  2023cites this paper
• Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

  2023cites this paper
• A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.

  2023cites this paper
• Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1

  2023cites this paper
• [The clinical impact of amino acid positron emission tomography measurements in the treatment of primary malignant brain tumors].

  2023cites this paper
• Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives

  2023cites this paper
• Contribution of nuclear medicine to the diagnosis and management of primary brain tumours.

  2023cites this paper
• Hybrid 18F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors

  2023influential citation
• Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT

  2022cites this paper